Made With Uberflip Content Marketing

Youtube - BIO-Europe Spring® 2016

This stream includes all videos from our BIO-Europe Spring® 2016 YouTube playlist.

  • BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup10:21

    BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup

    Dr. Ilan Zipkin, senior investment director at Takeda Ventures, talks with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about what the venture capital fi

    Watch Video
  • BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?9:27

    BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?

    Dr. Thomas Zioncheck, senior director of Genentech Partnering (a unit of Roche subsidiary Genentech Inc.), speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights po

    Watch Video
  • BIO-Europe Spring® 2016: AZ BioVenture Hub CEO says aim is an innovative ecosystem12:46

    BIO-Europe Spring® 2016: AZ BioVenture Hub CEO says aim is an innovative ecosystem

    AstraZeneca’s BioVentureHub CEO Magnus Björsne tells Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the exchange's intention to generate a climate of

    Watch Video
  • BIO-Europe Spring® 2016: Sixth Element Capital outlines healthcare investment strategy11:53

    BIO-Europe Spring® 2016: Sixth Element Capital outlines healthcare investment strategy

    Ian A. Miscampbell, managing partner at Sixth Element Capital speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio about the private UK-based investment

    Watch Video
  • BIO-Europe Spring® 2016: RMI says it has USD 200 million already under management7:49

    BIO-Europe Spring® 2016: RMI says it has USD 200 million already under management

    Maxim Gorbachev, a partner and portfolio manager at RusnanoMedInvest (RMI) speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio about Russia’s and Easte

    Watch Video
  • BIO-Europe Spring® 2016: Achelous Partners is built on knowing life sciences and finance sectors10:02

    BIO-Europe Spring® 2016: Achelous Partners is built on knowing life sciences and finance sectors

    The European Representative of Achelous Partners, Jan Boesen, explains the investment bank's strategy and strengths to Mike Ward, global director of content for Informa Pharma Intelligence's insights

    Watch Video
  • BIO-Europe Spring® 2016: Seventure Partners targets the microbiome revolution10:51

    BIO-Europe Spring® 2016: Seventure Partners targets the microbiome revolution

    Eric de la Fortelle, venture partner with Seventure Partners in charge of investments in the Benelux, Scandinavia, Northern Switzerland and North America speaks to Mike Ward, global director of conten

    Watch Video
  • BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances8:36

    BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances

    Shara Avis, business development specialist at MD Anderson Cancer Center—a world-renown research center—speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portf

    Watch Video
  • BIO-Europe Spring® 2016: Italy's A. Menarini IFR aims to expand into the US and Japan5:43

    BIO-Europe Spring® 2016: Italy's A. Menarini IFR aims to expand into the US and Japan

    A. Menarini IFR corporate licensing director Giammario Piras speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden, about the

    Watch Video
  • BIO-Europe Spring® 2016: BeyondSpring Pharmaceuticals outlines Plinabulin plans8:15

    BIO-Europe Spring® 2016: BeyondSpring Pharmaceuticals outlines Plinabulin plans

    Watch Video
  • BIO-Europe Spring® 2016:  Accellta CEO says israeli stem cell specialist seeks global partners4:12

    BIO-Europe Spring® 2016: Accellta CEO says israeli stem cell specialist seeks global partners

    Accellta CEO Itzchak Angel speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the Israeli stem cell specialist's ste

    Watch Video
  • BIO-Europe Spring® 2016: AngioDesign tailoring next-generation ACE inhibitors5:07

    BIO-Europe Spring® 2016: AngioDesign tailoring next-generation ACE inhibitors

    Mario Ehlers, the chairman and founder of Angio-Design (UK) speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the d

    Watch Video
  • BIO-Europe Spring® 2016: 4SC AG's CSO outlines epigenetics strategy5:14

    BIO-Europe Spring® 2016: 4SC AG's CSO outlines epigenetics strategy

    4SC AG Chief Science Officer Daniel Vitt speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden, outlining how the German canc

    Watch Video
  • BIO-Europe Spring® 2016: Agalimmune brings novel immune-oncology therapy from US to UK9:25

    BIO-Europe Spring® 2016: Agalimmune brings novel immune-oncology therapy from US to UK

    Damian Marron, CEO of Agalimmune Ltd., speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the company's novel immuno-oncology technology and ho

    Watch Video
  • BIO-Europe Spring® 2016: Where can Adocia fit in the diabetes market?11:28

    BIO-Europe Spring® 2016: Where can Adocia fit in the diabetes market?

    Dr. Remi Soula, co-founder and director of business development and intellectual property at Adocia, chats with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfol

    Watch Video
  • BIO-Europe Spring® 2016: Motif's CEO on business leap from discovery to clinical-stage biotech9:04

    BIO-Europe Spring® 2016: Motif's CEO on business leap from discovery to clinical-stage biotech

    Dr. Graham Lumsden, CEO of London-based biotech Motif Bio, a company focused on the development of therapeutics for infectious diseases, talks with Mike Ward, global director of content for Informa Ph

    Watch Video
  • BIO-Europe Spring® 2016: Purdue CEO outlines plans for growth away from opioid market12:39

    BIO-Europe Spring® 2016: Purdue CEO outlines plans for growth away from opioid market

    During the 2016 BIO-Europe Spring® partnering meeting in Stockholm, Sweden, Mark Timney, president and CEO of Purdue Pharma, caught up with Mike Ward, global director of content for Informa Pharma Int

    Watch Video
  • BIO-Europe Spring® 2016: PILA Pharma CEO explains potential of "chili receptor" as diabetes therapy9:58

    BIO-Europe Spring® 2016: PILA Pharma CEO explains potential of "chili receptor" as diabetes therapy

    Dr. Dorte Gram, CEO of PILA Pharma AB, one of Sweden's youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about PILA's his

    Watch Video
  • BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?9:27

    BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?

    Dr. Thomas Zioncheck, senior director of Genentech Partnering (a unit of Roche subsidiary Genentech Inc.), speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights po

    Watch Video
  • BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence5:32

    BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence

    Anne-Marie Wenthzel, VP of business development at Sprint Bioscience, chats with Sten Stovall during the BIO-Europe Spring partnering conference in Stockholm, Sweden, about the company's business mode

    Watch Video
  • loading
    Loading More...